首页 | 本学科首页   官方微博 | 高级检索  
检索        


A novel nano-structured porous polycaprolactone scaffold improves hyaline cartilage repair in a rabbit model compared to a collagen type I/III scaffold: in vitro and in vivo studies
Authors:Bjørn Borsøe Christensen  Casper Bindzus Foldager  Ole Møller Hansen  Asger Albæk Kristiansen  Dang Quang Svend Le  Agnete Desirée Nielsen  Jens Vinge Nygaard  Cody Erik Bünger  Martin Lind
Institution:1. Orthopaedic Research Laboratory, Aarhus University Hospital, N?rrebrogade 44, Build. 1A, 1. Floor, 8000, Aarhus C, Denmark
2. Interdisciplinary Nanoscience Center, Aarhus University, Ny Munkegade 120, 8000, Aarhus C, Denmark
3. Department of Radiology, Silkeborg Regional Hospital, Falkevej 1-3, 8600, Silkeborg, Denmark
4. Department of Orthopaedic Surgery, The Sports Trauma Clinic, Aarhus University Hospital, Tage Hansens Gade 2, 8000, Aarhus C, Denmark
Abstract:

Purpose

To develop a nano-structured porous polycaprolactone (NSP-PCL) scaffold and compare the articular cartilage repair potential with that of a commercially available collagen type I/III (Chondro-Gide®) scaffold.

Methods

By combining rapid prototyping and thermally induced phase separation, the NSP-PCL scaffold was produced for matrix-assisted autologous chondrocyte implantation. Lyophilizing a water–dioxane–PCL solution created micro and nano-pores. In vitro: The scaffolds were seeded with rabbit chondrocytes and cultured in hypoxia for 6 days. qRT–PCR was performed using primers for sox9, aggrecan, collagen type 1 and 2. In vivo: 15 New Zealand White Rabbits received bilateral osteochondral defects in the femoral intercondylar grooves. Autologous chondrocytes were harvested 4 weeks prior to surgery. There were 3 treatment groups: (1) NSP-PCL scaffold without cells. (2) The Chondro-Gide® scaffold with autologous chondrocytes and (3) NSP-PCL scaffold with autologous chondrocytes. Observation period was 13 weeks. Histological evaluation was made using the O’Driscoll score.

Results

In vitro: The expressions of sox9 and aggrecan were higher in the NSP-PCL scaffold, while expression of collagen 1 was lower compared to the Chondro-Gide® scaffold. In vivo: Both NSP-PCL scaffolds with and without cells scored significantly higher than the Chondro-Gide® scaffold when looking at the structural integrity and the surface regularity of the repair tissue. No differences were found between the NSP-PCL scaffold with and without cells.

Conclusion

The NSP-PCL scaffold demonstrated higher in vitro expression of chondrogenic markers and had higher in vivo histological scores compared to the Chondro-Gide® scaffold. The improved chondrocytic differentiation can potentially produce more hyaline cartilage during clinical cartilage repair. It appears to be a suitable cell-free implant for hyaline cartilage repair and could provide a less costly and more effective treatment option than the Chondro-Gide® scaffold with cells.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号